ProUroCare Medical conducts much of its R&D, clinical, regulatory, and reimbursement activities in collaboration with key people and organizations, including:
Artann Laboratories (Artann) is an innovative technology portfolio holding company with a mission of early stage development and validation of novel technologies and devices. The company was founded in New Jersey in 1995 by Armen and Tatyana Sarvazyan and is now operated by a team of scientific research professionals who brought their expertise, experience and drive to succeed from the former Soviet Union.
Artann is a recipient of over twenty grant and contract awards from the various institutes of the National Institutes of Health, as well as NASA and the Department of Defense.
Within less then a decade, Artann has built a solid intellectual property foundation for its technologies with over 30 issued and pending US patents. Furthermore, the company has established a sound record of transforming new technologies from academic ideas into functional prototypes ready for commercialization. To date, Artann has spun-off five technologies into separate companies to carry out the commercialization of its products.
Hogan & Hartson With over 1,000 lawyers practicing in 21 offices worldwide, Hogan & Hartson works seamlessly across multiple practices and offices to provide their clients with exceptional service and creative advice. Hogan & Hartson’s food, drug, medical device, and agriculture practice is one of the most unique, dynamic and comprehensive in the country. Whether the project entails helping a start-up company obtain marketing approval from the U.S. Food and Drug Administration (FDA) for a life-saving therapy; representing a multi-national corporation in a U.S. Department of Justice criminal investigation; counseling a food company on compliance with FDA and U.S. Department of Agriculture (USDA) inspection, food safety and labeling requirements; or navigating the federal bioterrorism laws; their attorneys and regulatory affairs specialists use their extensive, diverse experience to develop effective solutions to client needs.
The firm is consistently ranked among the top global law firms in industry surveys and major publications. The Legal Business ‘Global 50 Survey’, August 2004, lists Hogan & Hartson as a “Top 30” global law firm (by revenue). The American Lawyer named our litigation department one of the “most valuable players” in its most recent biennial survey of the top U.S. law firms’ litigation departments. Global Counsel 3000 observes, “In less than 15 years, Hogan & Hartson has established itself as one of the most committed of the U.S. law firms in Europe.” Chambers USA ranks several of our offices and practices #1 in their markets.
Ray Kasevich is President and Chief Scientist of C S Medical technologies, LLC, a corporation founded for the purpose of research, development, manufacture, and technology licensing of diagnostic and therapeutic electromagnetic devices for medical applications. The electromagnetic technologies originated from Mr. Kasevich’s extensive experience in developing microwave balloon angioplasty catheter systems for C.R. Bard, radiofrequency bipolar catheter systems for USSC in Connecticut, and experimental work with novel hyperthermic catheter antenna systems.
Minnetronix, a Minnesota-based company, is a world-class developer and manufacturer of electronic and software systems for medical devices. They specialize in the rapid design, commercialization, and manufacture of highly integrated and miniaturized systems in partnership with medical device companies. Their projects range in scope from new product design and development to existing product upgrades to manufacturing low and mid-volume quantities of highly-complex electromechanical assemblies. They develop and manufacture FDA Class I, Class II, and Class III medical devices. Founded in 1996 by three former 3M engineers, Minnetronix has grown to over 80 employees in nine years, and continues to grow and expand.
Rensselaer Polytechnic Institute (RPI), Troy , NY. Throughout its history, Rensselaer research has produced ground-breaking work in a broad range of important areas. Early RPI engineering graduates built bridges that linked people, commerce and communities. Today, Rensselaer people are building the bridges that will link the world to the promises of new technologies.
The collaborative efforts of their students, faculty, corporate partners and government agencies are generating a new momentum in research and the development of innovative technologies, including biotechnology, information technology and nanotechnology.
Creating and applying knowledge, and interdisciplinary inquiry, with a rigorous approach to solving problems, Rensselaer men and Rensselaer women are fulfilling the university’s role as a place where people find innovative solutions to complex technical challenges.
Neal Shore , MD, FACS completed his Bachelor of Arts degree and graduated magna cum laude from Duke University in 1980. He received his medical degree from Duke University in 1983. Dr. Shore completed a six-year residency in general surgery and urology at New York Hospital-Cornell Medical Center, a clinical fellowship at Memorial-Sloan Kettering Cancer Center and a research fellowship at the University of Pretoria, South Africa. He has several publications in the Journal of Urology. Dr. Shore has served as the chairman of the American College of Surgeons.